The Challenge of Slowing Diabetic Kidney Disease Progression and Reducing Cardiovascular Risk: Recent Advances and Novel Strategies
Diabetic kidney disease (DKD) remains one of the major causes of morbidity and mortality in patients with type 2 diabetes. Despite optimized glycemic control and renin-angiotensin-aldosterone system (RAAS) inhibitor therapy, many patients with DKD progress to kidney failure.
Category
  • CMHC
Format
  • Monograph
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • Participation
Clinical Brief: Antithrombotic and Antiplatelet Therapy in the Cardiometabolic Patient
This clinical brief, adapted from a presentation at the 2021 CMHC Spring meeting, offers a concise overview of recent trials and developments in antithrombotic and antiplatelet therapy in high-risk cardiometabolic patients with coronary artery disease (CAD) or peripheral artery disease (PAD). 
Category
  • CMHC
Format
  • Monograph
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • CDE
  • Participation
Virtual Symposium - The Nexus of Narcolepsy and Cardiometabolic Risk: Important Considerations and Implications for Management
Several cardiometabolic comorbidities, including overweight/obesity, dyslipidemia, cardiovascular diseases, hypertension, and type 2 diabetes or insulin resistance, are common in patients with narcolepsy.  Often these disorders are overlooked, but they have important implications in the managemen
Category
  • CMHC
Format
  • Video
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • CDE
  • Participation
Clinical Brief: Use of Insulin Pumps in the Management of Type 2 Diabetes: A Review of Guidelines and Evidence
This clinical brief, adapted from a presentation at the 2021 CMHC Spring meeting, offers an overview of insulin pumps and insulin delivery systems for T2DM, as well as expert feedback and practical strategies on how to integrate them to patient care.
Category
  • CMHC
Format
  • Monograph
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • CDE
  • Participation
3D Virtual Facial Anatomy and Injection Masterclass
Within the past decade, aesthetic medicine –particularly minimally invasive aesthetic practice – has significantly advanced.
Category
  • LivDerm
  • TME
Format
  • Video
Credits
  • AMA PRA Category 1 Credit
  • ANCC
  • Participation
Tackling the Disparities in the Management of Atopic Dermatitis in African Americans: The Time is Now
Atopic dermatitis (AD) is a chronic inflammatory and relapsing cutaneous disease characterized by pruritus, cutaneous inflammation, and transepidermal water loss (Krakowski 2008).
Category
  • LivDerm
  • TME
Format
  • Webinar recorded
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • Participation
Virtual Symposium: Addressing The Disproportionate Burden & Disparities with COVID-19
By now, it is established that the burden of cardiometabolic risk, including CVD, diabetes, atherosclerosis, hypertension, obesity, and more, are higher in certain racial and ethnic minorities, including African Americans, Latinos, and Native Americans.
Category
  • CMHC
Format
  • Video
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • CDE
  • Participation
CMHC Annual 2021 On Demand
The global epidemic of cardiometabolic disease demands the continual refinement of cardiometabolic care approaches and strategies. As the nation’s premier event in cardiometabolic medicine, the 16th Annual Cardiometabolic Health Congress
Category
  • CMHC
Format
  • Conference / meeting
  • Video
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • CDE
  • Participation
EDUCATIONAL PRIMER: A New Wave of Systemic Treatments: Atopic Dermatitis, Meet JAK
The increasing incidence of atopic dermatitis (AD) and poor recognition of the disease in some patient groups is a public health concern. AD symptoms and its daily management cause significant effects on quality of life for both patients and caregivers.
Category
  • LivDerm
  • TME
Format
  • Webinar recorded
Credits
  • AAPA Category I CME
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • Participation
Virtual Symposium: Lipid Management in Very High-Risk Patients Post-MI: Applying Real-World Evidence to Improve Outcome
Patients with a recent myocardial infarction (MI) are classified as very high-risk for future atherosclerotic cardiovascular disease (ASCVD) events according to current guidelines, however, targeted LDL-C achievement and optimization of lipid lowering therapy (LLT) in these patients remains subop
Category
  • CMHC
Format
  • Video
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • CDE
  • Participation

Pages